Literature DB >> 28207984

Structural Basis of Microtubule Stabilization by Discodermolide.

Andrea E Prota1, Katja Bargsten1,2, Mariano Redondo-Horcajo3, Amos B Smith4, Chia-Ping H Yang5, Hayley M McDaid5, Ian Paterson6, Susan B Horwitz5, José Fernando Díaz3, Michel O Steinmetz1.   

Abstract

Microtubule-stabilizing agents (MSAs) are widely used in chemotherapy. Using X-ray crystallography we elucidated the detailed binding modes of two potent MSAs, (+)-discodermolide (DDM) and the DDM-paclitaxel hybrid KS-1-199-32, in the taxane pocket of β-tubulin. The two compounds bind in a very similar hairpin conformation, as previously observed in solution. However, they stabilize the M-loop of β-tubulin differently: KS-1-199-32 induces an M-loop helical conformation that is not observed for DDM. In the context of the microtubule structure, both MSAs connect the β-tubulin helices H6 and H7 and loop S9-S10 with the M-loop. This is similar to the structural effects elicited by epothilone A, but distinct from paclitaxel. Together, our data reveal differential binding mechanisms of DDM and KS-1-199-32 on tubulin.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  X-ray crystallography; drug design; microtubules; molecular mechanism of action; structure elucidation

Mesh:

Substances:

Year:  2017        PMID: 28207984      PMCID: PMC5559732          DOI: 10.1002/cbic.201600696

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  29 in total

1.  (+)-Discodermolide: Total Synthesis, Construction of Novel Analogues, and Biological Evaluation.

Authors:  Amos B Smith; B Scott Freeze
Journal:  Tetrahedron       Date:  2007-01-07       Impact factor: 2.457

2.  The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide.

Authors:  Víctor M Sánchez-Pedregal; Karel Kubicek; Jens Meiler; Isabelle Lyothier; Ian Paterson; Teresa Carlomagno
Journal:  Angew Chem Int Ed Engl       Date:  2006-11-13       Impact factor: 15.336

3.  The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence.

Authors:  Laura E Klein; B Scott Freeze; Amos B Smith; Susan Band Horwitz
Journal:  Cell Cycle       Date:  2005-03-18       Impact factor: 4.534

Review 4.  Microtubule-binding agents: a dynamic field of cancer therapeutics.

Authors:  Charles Dumontet; Mary Ann Jordan
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

5.  The interaction of baccatin III with the taxol binding site of microtubules determined by a homogeneous assay with fluorescent taxoid.

Authors:  J M Andreu; I Barasoain
Journal:  Biochemistry       Date:  2001-10-09       Impact factor: 3.162

6.  Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.

Authors:  Marina Khrapunovich-Baine; Vilas Menon; Pascal Verdier-Pinard; Amos B Smith; Ruth Hogue Angeletti; Andras Fiser; Susan Band Horwitz; Hui Xiao
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

7.  The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin.

Authors:  Angeles Canales; Ruth Matesanz; Nicola M Gardner; José Manuel Andreu; Ian Paterson; J Fernando Díaz; Jesús Jiménez-Barbero
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

8.  The discodermolide hairpin structure flows from conformationally stable modular motifs.

Authors:  Ashutosh S Jogalekar; Frederik H Kriel; Qi Shi; Ben Cornett; Daniel Cicero; James P Snyder
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

9.  Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.

Authors:  E ter Haar; R J Kowalski; E Hamel; C M Lin; R E Longley; S P Gunasekera; H S Rosenkranz; B W Day
Journal:  Biochemistry       Date:  1996-01-09       Impact factor: 3.162

10.  Discodermolide interferes with the binding of tau protein to microtubules.

Authors:  Santwana Kar; Gordon J Florence; Ian Paterson; Linda A Amos
Journal:  FEBS Lett       Date:  2003-03-27       Impact factor: 4.124

View more
  6 in total

1.  Structural Refinement of the Tubulin Ligand (+)-Discodermolide to Attenuate Chemotherapy-Mediated Senescence.

Authors:  Boying Guo; Alicia Rodriguez-Gabin; Andrea E Prota; Tobias Mühlethaler; Nan Zhang; Kenny Ye; Michel O Steinmetz; Susan Band Horwitz; Amos B Smith; Hayley M McDaid
Journal:  Mol Pharmacol       Date:  2020-06-26       Impact factor: 4.436

Review 2.  Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products.

Authors:  April L Risinger; Lin Du
Journal:  Nat Prod Rep       Date:  2019-11-25       Impact factor: 13.423

3.  Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule.

Authors:  Pedro A Sánchez-Murcia; Alberto Mills; Álvaro Cortés-Cabrera; Federico Gago
Journal:  J Comput Aided Mol Des       Date:  2019-05-31       Impact factor: 3.686

4.  Improved Dose-Response Relationship of (+)-Discodermolide-Taxol Hybrid Congeners.

Authors:  Celine Nadaradjane; Chia-Ping Huang Yang; Alicia Rodriguez-Gabin; Kenny Ye; Keizo Sugasawa; Onur Atasoylu; Amos B Smith; Susan Band Horwitz; Hayley M McDaid
Journal:  J Nat Prod       Date:  2018-03-09       Impact factor: 4.050

Review 5.  Utilization of Photoaffinity Labeling to Investigate Binding of Microtubule Stabilizing Agents to P-Glycoprotein and β-Tubulin.

Authors:  Chia-Ping Huang Yang; Susan Band Horwitz; Hayley M McDaid
Journal:  J Nat Prod       Date:  2022-03-03       Impact factor: 4.803

6.  Zampanolide, a Microtubule-Stabilizing Agent, Is Active in Resistant Cancer Cells and Inhibits Cell Migration.

Authors:  Jessica J Field; Peter T Northcote; Ian Paterson; Karl-Heinz Altmann; J Fernando Díaz; John H Miller
Journal:  Int J Mol Sci       Date:  2017-05-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.